Biomedical Companies Inject Innovation Into Cancer Radiotherapy

Recent U.S. Food and Drug Administration approvals of new treatments, plus promising data from some experimental medicines, are spurring venture-capital investment in new companies and prompting drugmakers to acquire radiopharmaceutical startups.

Bezos’ Blue Origin Rebuffed in Contract Protest

A federal agency upheld the decision to make Elon Musk’s SpaceX...

Scarlett Johansson’s Agent Rips Disney Over ‘Black Widow’ Dispute

Creative Artists Agency has stepped into the fight between Scarlett Johansson...

Biden to Tap Artificial Intelligence Expert as Top Business Diplomat

Stanford professor Ramin Toloui is the president’s pick for assistant secretary...

Elon Musk’s ‘Delivery Hell’

September of 2018 was a do-or-die moment for Tesla. The auto...